High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for “De Novo” Multiple Myeloma Patients: A Phase II Study Maurizio Musso, Giuseppe Messina, Gianpaolo Marcacci, Alessandra Crescimanno, Giuseppe Console, Daniela Donnarumma, Renato Scalone, Antonio Pinto, Massimo Martino Biology of Blood and Marrow Transplantation Volume 21, Issue 11, Pages 1932-1938 (November 2015) DOI: 10.1016/j.bbmt.2015.06.011 Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 Day 100 response rates after transplant. PR indicates partial response. Biology of Blood and Marrow Transplantation 2015 21, 1932-1938DOI: (10.1016/j.bbmt.2015.06.011) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 Progression-free survival. Biology of Blood and Marrow Transplantation 2015 21, 1932-1938DOI: (10.1016/j.bbmt.2015.06.011) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 3 Overall survival. Biology of Blood and Marrow Transplantation 2015 21, 1932-1938DOI: (10.1016/j.bbmt.2015.06.011) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions